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Abstract
Bacterial small RNAs (sRNAs) are short transcripts that typically do not encode proteins and often act as regulators of gene
expression through a variety of mechanisms. Regulatory sRNAs have been identified in many species, including
Mycobacterium tuberculosis, the causative agent of tuberculosis. Here, we use a computational algorithm to predict sRNA
candidates in the mycobacterial species M. smegmatis and M. bovis BCG and confirmed the expression of many sRNAs using
Northern blotting. Thus, we have identified 17 and 23 novel sRNAs in M. smegmatis and M. bovis BCG, respectively. We have
also applied a high-throughput technique (Deep-RACE) to map the 59 and 39 ends of many of these sRNAs and identified
potential regulators of sRNAs by analysis of existing ChIP-seq datasets. The sRNAs identified in this work likely contribute to
the unique biology of mycobacteria.
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Introduction
The genus Mycobacterium contains many clinically relevant
pathogens, including Mycobacterium tuberculosis and Mycobacterium
leprae, the etiologic agents of tuberculosis (TB) and leprosy,
respectively. M. tuberculosis alone was responsible for 8.7 million
incident cases and 1.4 million deaths globally in 2011 [1]. The
treatment of TB has become increasingly difficult due to its high
drug resistance and adaptability; hence, the development of new
and more effective treatments for TB is imperative.
Bacterial ‘‘small RNAs’’ (sRNAs) are small (50–400 nt), typically
untranslated transcripts. Many sRNAs play important roles in
gene regulation in response to environmental changes [2]. sRNAs
can originate from their own independent genes or through the
processing of larger transcripts [3]. To exert their function, sRNAs
typically base-pair with target messenger RNAs (mRNAs),
resulting in altered transcription, mRNA stability, or translation
[4]. sRNAs are key regulators of pathogenesis in many bacterial
species [5]. Recently, RNA-seq has been widely applied to identify
novel sRNA candidates in many bacterial species [6–10],
including M. tuberculosis [11]. sRNAs have also been identified/
predicted in M. tuberculosis using other experimental approaches
[12–14] and computational analysis of DNA sequence [13,15,16].
In total, 63 sRNAs have been experimentally validated in M.
tuberculosis. sRNAs have also been identified in other mycobacterial
species: 34 and 15 sRNAs have been experimentally validated in
Mycobcaterium bovis BCG and Mycobacterium smegmatis, respectively
[13].
In a previous study, we used computational predictions from the
SIPHT (sRNA Identification Protocol using High-throughput
Technologies) [17] algorithm to identify 144 sRNA candidates in
M. bovis BCG. We selected 34 conserved sRNA candidates which
we experimentally confirmed by Northern blot [13]. In the current
study, we expanded our search to include all the remaining
SIPHT predictions for M. bovis BCG as well as all SIPHT
predictions for M. smegmatis (these were not explored in the
previous study). By combining SIPHT predictions with large-scale
Northern blot validation, we have identified 23 and 17 novel
sRNAs in M. bovis BCG and M. smegmatis, respectively. Thus, we
have substantially increased the number of experimentally
validated sRNAs in mycobacterial species. We also analyzed
existing ChIP-seq datasets to identify possible regulators of sRNA
expression, and used Deep-RACE, a technique that combines
high throughput RNA-seq with Rapid Amplification of cDNA
Reads (RACE) [18], to identify sRNA 59 and 39 ends. Lastly, it is
worth noting that this work is one of the first efforts to better
coordinate genome annotation; all sRNA candidates identified in
this study have been renamed with a new nomenclature [19].
Materials and Methods
Strains and Plasmids
M. bovis BCG (Pasteur strain, Trudeau Institute), and M.
tuberculosis H37Rv were grown in mycomedium (as previously
reported, [13]). M. bovis BCG and M. tuberculosis cultures were
grown for 7 days, with shaking, to late-log phase. Cultures of M.
smegmatis MC
2155 were grown shaking at 37uC, in trypticase soy
media supplemented with 0.05% Tween 80 for 18 hours with
shaking (late-log phase).
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sRNA Candidates
Small RNA candidates of M. smegmatis were predicted using the
SIPHT program with the same parameters as described previously
[17,20]. SIPHT identifies potential sRNA candidates based on the
presence of intergenic sequence conservation upstream of putative
Rho-independent terminators. SIPHT has been widely applied in
sRNA studies [21–23], and its reliability has been tested and
compared with other algorithms [24].
RNA Isolation and Northern Blot Analysis
RNA was isolated as previously reported [13]. Northern blot
analysis was performed as previously reported [13]; probes were
designed according to SIPHT predicted sequences and tested in
M. bovis BCG, M. smegmatis and M. tuberculosis [13]. All the
oligonucleotides that were used in this study are listed in Table S1.
ChIP-seq Analysis
We analyzed existing ChIP-seq datasets for 55 M. tuberculosis
transcription factors extracted from a previous study [25]. ChIP-
seq peak positions were compared to the 59 end positions of M.
bovis BCG and M. tuberculosis sRNAs from the current study and
two previous studies [12,15]. For M. bovis BCG sRNAs, we first
identified the equivalent region of the M. tuberculosis H37Rv
genome. Possible sRNA regulators were selected if the ChIP-seq
peak was located within 100 bp upstream and 20 bp downstream
of an sRNA 59 end.
Deep 59 and 39 RACE
Deep 59 RACE and Deep 39 RACE were performed as
previously described [18] with the following exceptions. Deep 59
RACE libraries and Deep 39 RACE libraries were pooled and
sequenced together using an Ion Torrent 316 chip (Wadsworth
Center Applied Genomic Technologies Core Facility). For Deep
59 RACE, sequence reads were identified by the presence of the
expected adapter sequence at the read 59 end. Adapter sequences
were removed and reads of .40 nt were mapped to the reference
genomes using BWA [26]. For Deep 39 RACE, sequence reads
were identified by the presence of the expected adapter sequence.
Figure 1. Schematic for sRNA identification. This schematic shows
the combination of computational approaches and Northern blotting
analysis used to identify the reported novel sRNAs in M. bovis BCG and
M. smegmatis.
doi:10.1371/journal.pone.0079411.g001
Figure 2. Northern blotting confirmation of sRNA candidates in M. smegmatis. Selected images of Northern blotting analysis for validated
M. smegmatis sRNAs; the remaining images are included in Figure S1. Lane 1 and 2 indicate total RNA samples extracted from M. smegmatis and M.
bovis BCG, respectively. We used Phi-X174/Hae III Marker for the size prediction. The probes we used for this analysis are listed in Table S1.
doi:10.1371/journal.pone.0079411.g002
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removed by identifying the first consecutive pair of bases not
including a ‘‘T’’ and removing all sequence upstream of this.
Sequences of .40 nt were mapped to the reference genomes using
BWA [26]. For both Deep 59 RACE and Deep 39 RACE, 59 and
39 ends were identified as the position with the most sequence
reads, and with a minimum of 5 reads. Sequences of all primers
used for Deep RACE are listed in Table S2.
Results and Discussion
Prediction of sRNAs in silico using SIPHT
Using SIPHT, we identified 93 candidate sRNAs in M. smegmatis
(refseq: NC_008596) (Table S3) and 144 candidate sRNAs in M.
bovis BCG (refseq: NC_008769) (Table S4). Tables S3 and S4
include a detailed description of the predicted coordinates,
orientations, sizes and neighboring upstream and downstream
genes. Northern probes were designed according to SIPHT
prediction. Figure 1 summarizes the overall approach that was
employed in this work for sRNA identification and confirmation.
17 Novel sRNAs Identified in Mycobacterium Smegmatis
All 93 M. smegmatis sRNA candidates were tested by Northern
blot using oligonucleotides in both orientations; expression was
confirmed for 18 sRNA (listed in Table 1; see blot pictures in
Figure 2 and Figure S1). One of them (Sm32/33) was identified in
recent work as IGR-1 with similar size, coordinates and same
orientation [27]. Thus, 17 M. smegmatis sRNAs identified here
have not been experimentally demonstrated in any previous
studies. In our previous study [13], we reported homologs of 6 M.
smegmatis sRNA candidates (Sm32/Sm33, Sm35, Sm46, Sm47,
and Sm74) in M. bovis BCG (Mpr13/Mcr14, Mpr20, Mpr3, Mpr4,
and Mpr5, respectively). These were confirmed directly in M.
smegmatis by Northern blotting in current study and listed in the 17
novel confirmed sRNAs. A homologue of Sm76 was previously
identified in M. tuberculosis by RNA-seq [15] and microarray
analysis [14] but not otherwise experimentally confirmed. All of
the validated sRNAs were in the same orientation to that predicted
by SIPHT. This suggests that the sequence specificity of SIPHT
for this prediction is higher than in our previous work, in which 9
out of 37 of the validated sRNAs were in the opposite orientation
to the prediction [13]. All confirmed sRNAs were assigned gene
names according to a recently-proposed nomenclature [19].
Table 1. sRNAs confirmed by Northern blotting analysis in M. smegmatis.
Homology confirmed by
Northern analysis in:
59 end* 39 end* M. bovis BCG M. tuberculosis New nomenclature
Length Confirm by Northern
blotting analysis(nt)
Intergenic sRNAs
Sm19 5029661 5029530 ncMSMEG14931Ac 100–118
Sm32/33
# 417709 417796 3 ncMSMEG10373A 44
Sm35 1458488 1458562 3 ncMSMEG11363A 118
Sm46 5864890 5864989 3 ncMSMEG15796A 82
Sm49 1086797 1087035 ncMSMEG11016A 48–66
Sm64 2523008 2522888 33 ncMSMEG12439Ac 100–118
Sm76 3690377 3690280 33 ncMSMEG13628Ac 100–118
Sm82 4392939/4392970 4393039 3 ncMSMEG14302A 66/82–100
Total overlapping sense sRNAs
Sm38 2236980 2237466 3 ncMSMEG2161A 48–66/66–82
Sm41 3815700/3815647 3815581 3 ncMSMEG3749Ac 48–66/100–118
Sm90 6845964 6846035 33 ncMSMEG6799A 48–66
Sm93 858482 858588 3 ncMSMEG0774A 66–82/100–118
Total overlapping antisense sRNAs
Sm42 4290417/4290487 4290537 33 ncMSMEG4206A 48–66/100–118
Sm67 2600405/2600425 2600485 ncMSMEG2514A 48–66/66–82
Sm68 2600389 2600701 ncMSMEG2514B 82–100
Sm74 3111233 3111268 3 ncMSMEG3037A 66–82
Partial overlapping antisense sRNAs
Sm11 2835860 2835984/
2835999
3 ncMSMEG12771A 100–118/140–151
Not categorized sRNAs
Sm47 6242319 6242668 3 ncMSMEG16173A 311
*The coordinates in bold were determined by 59 or 39 Deep-RACE. Where only one end was determined by Deep RACE, the other end was estimated based on the size
determined by Northern blot. Where neither end was determined by Deep RACE, SIPHT-predicted coordinates are listed (underlined text).
#Experimentally demonstrated in previous study [27].
doi:10.1371/journal.pone.0079411.t001
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species simultaneously to search for novel sRNA candidates, we
used the designed probes for sRNA detection in M. smegmatis to
also probe expression of these candidates in M. bovis BCG and M.
tuberculosis. Although our focus was to validate M. smegmatis
predictions, we fortuitously discovered homologues of 9 candidates
in M. bovis BCG and 4 candidates in M. tuberculosis (Table 1, Figure
S2). Since these probes were not specifically designed for the other
two species, lack of detection could be due to either the absence of
sRNA expression or to non-optimization of the probe sequence
that was used for hybridization to the targeted region in the M.
bovis BCG and M. tuberculosis genome. Also, differences in culture
medium might contribute to the low number of expressed
homologous sRNAs of M. smegmatis in M. tuberculosis as expression
of these sRNAs could be specific to different conditions in M.
tuberculosis. Given our focus in sRNA identification, specific
conditions that could lead to differences in sRNA expression will
be explored in future work.
23 Novel sRNAs Identified in Mycobacterium Bovis BCG
Twenty-one of the sRNA candidates for M. bovis BCG (Bo12,
Bo15, Bo41, Bo52, Bo58, Bo67, Bo68, Bo75, Bo80, Bo85, Bo99,
Bo100, Bo111, Bo113, Bo115, Bo117, Bo122, Bo125, Bo126,
Bo137, and Bo139) were previously identified, under the
nomenclature Mpr 1–21, respectively [13]. Forty-six other
candidates were also tested previously but showed no signal;
therefore, only the remaining 77 candidates were tested using
Northern blotting analysis in this study, and we confirmed
expression of 23 new sRNA candidates (Figure 3 and Figure S3).
A homologue of Bo46 was previously identified in M. tuberculosis by
RNA-seq [15] but not otherwise experimentally validated. All of
the validated sRNAs were in the same orientation as that predicted
by SIPHT. We also applied the probes to M. smegmatis and M.
tuberculosis and identified 20 and 5 sRNA homologues, respectively
(Table 2; Figure 3; Figure S3). All the confirmed sRNAs in M. bovis
BCG and M. tuberculosis are listed in Table 2, along with the new
nomenclature for sRNAs.
Deep-RACE Identifies sRNA 59 and 39 Ends
We used Deep-RACE, a previously described approach that
combines conventional RACE and deep sequencing to identify 59
and 39 ends of selected RNAs [18,28]. In total, we identified 59
ends for 9 sRNAs and 39 ends for 21 sRNAs. Examples are shown
in Figure 4. For some sRNAs we identified multiple 59/39 ends.
Multiple 59 ends could be due to multiple transcription start sites
or RNA processing. Multiple 39 ends could be due to RNA
processing or may indicate imprecise Rho-dependent termination
of transcription.
Size Comparisons between Experimental and Prediction
Analysis
As noted in our earlier study [13], the predicted size of the
candidate sRNAs correlates only weakly with experimental
observations. Only about 17% of the confirmed sRNAs were
within 10% of their predicted sizes. Additionally, in many cases,
multiple bands were detected by Northern analysis, suggesting the
presence of multiple start sites, multiple termination sites, and/or
sRNA processing. This is consistent with the Deep RACE data
(Figure 4; Figure S4). Deep RACE identified both 59 and 39 ends
for seven sRNAs. In these cases, the sizes determined by Deep
RACE are similar to those confirmed by Northern blotting.
Location of sRNAs with Respect to Genes
To investigate the potential roles of the novel sRNAs, we
mapped them all to the latest annotated genome (National Center
for Biotechnology Information, NCBI). Although we aimed to find
intergenic sRNAs, half of the candidates we identified in this study
overlap partially or entirely protein-coding genes in either the
Figure 3. Northern blotting confirmation of sRNA candidates in M. bovis BCG. Selected images of Northern blotting analysis for validated M.
bovis BCG sRNAs; the remaining images are included in Figure S2. Lane 1 and 2 indicate total RNA samples extracted from M. bovis BCG and M.
smegmatis, respectively. We used Phi-X174/Hae III Marker for the size prediction. The probes we used for this analysis are listed in Table S1.
doi:10.1371/journal.pone.0079411.g003
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sRNAs into different classes according to their position relative to
adjacent coding regions. Where possible, we used 59/39 end
information from Deep-RACE data. For sRNAs that have only
one end mapped by Deep-RACE, the other end was estimated
according to the length confirmed by Northern blotting analysis
(Figure 4). For sRNAs that have neither end mapped by Deep-
RACE, the farthest possible ends were estimated according to
Northern blotting analysis and the sRNAs would be categorized as
‘‘not determined’’ if multiple class options exist.
Nine sRNAs in M. smegmatis (Sm19, Sm32/33, Sm35, Sm46,
Sm49, Sm64, Sm76, Sm82) and twelve sRNAs in M. bovis BCG
(Bo35, Bo48, Bo53, Bo60, Bo71, Bo73, Bo78, Bo86, Bo101,
B0105, Bo118, Bo132) were mapped completely to intergenic
regions. Four sRNAs in M. smegmatis (Sm38, Sm41, Sm90, Sm93)
were mapped to the sense strand of annotated protein-coding
genes, and four were mapped to the antisense strand (Sm42,
Sm67, Sm68, Sm74). One sRNA in M. smegmatis (Sm11) and five
in M. bovis BCG (Bo32, Bo47, Bo81, Bo96, Bo130) overlap
partially with adjacent genes in the antisense orientation, and four
sRNAs in M. bovis BCG (Bo27, Bo46, Bo82, Bo87) overlap
partially with adjacent genes in the sense orientation. One sRNA
in M. smegmatis (Sm47) and two in M. bovis BCG (Bo13, Bo29) were
not classified.
The location of sRNAs relative to protein-coding genes also
gives clues as to their function. Regulatory sRNAs that are
completely intergenic typically function by base-pairing with
distally-encoded mRNAs; however, some of the sRNAs are close
to the 59 end or 39 end of adjacent genes, suggesting possible
alternative regulatory roles. sRNAs antisense to ORFs or UTRs
can regulate expression of the overlapping gene [29]. sRNAs
located within UTRs or ORFs in the sense orientation may be
degradation products or mRNAs or could be important cis-acting
regulatory elements such as riboswitches.
Table 2. sRNAs confirmed by Northern blotting analysis in M. Bovis BCG.
Homology confirmed by Northern
analysis in:
59 end* 39 end* M. smegmatis M. tuberculosis New nomenclature
Length Confirm by Northern blotting
analysis(nt)
Intergenic sRNAs
Bo35 576179 576067/576104 3 ncBCG10493Ac 48–66/82–100
Bo48 3028936 3028876 33 ncBCG12782Ac 48–66
Bo53 1044606 1044706/
1044720/
1044727
3 ncBCG10960A 82–100/100–118
Bo60 1247638 1247538 3 ncBCG11150Ac 66/100
Bo71 1588853 1588693 33 ncBCG11448Ac 66
Bo73 1647817 1647853 3 ncBCG11504A 66–82
Bo78 207337 207179 33 ncBCG10186Ac 66/100
Bo86 2325795 2325960 3 ncBCG12107A 66–82
Bo101 2919337 2919277 3 ncBCG2654Ac 48–66
Bo118 3765977 3765917 3 ncBCG13438Ac 48–66
Bo132 4260533 4260610 3 ncBCG13885A 66–82
Bo105 3073445 3073541 ncBCG12831A 66–82
Partial overlapping sense sRNAs
Bo27 2157804 2157704 3 ncBCG11948Ac 82–100
Bo46 2603016 2602916 33 ncBCG12368Ac 100
Bo82 2235286 2235196 3 ncBCG12024Ac 82–100
Bo87 2351000/
2351046
2350915/
2350874
33 ncBCG12128Ac 48–66/66–82/82
Partial overlapping antisense sRNAs
Bo32 817571 817483 3 ncBCG10734Ac 66–82/82
Bo47 2705925/
2705838
2705735 ncBCG12462Ac 82–100
Bo81 218700 2187796 3 ncBCG10195A 66/100
Bo96 2686849 2686909/2686989 3 ncBCG12441A 66–82/118–142
Bo130 413416 413288 3 ncBCG0352Ac 66–82/118–142
Not categorized sRNAs
Bo13 3126934 3127070 ncBCG12882A 48–66/82–100
Bo29 1770012 1769806 3 ncBCG11603Ac 66–82
*The coordinates in bold were determined by 59 or 39 Deep-RACE. Where only one end was determined by Deep RACE, the other end was estimated based on the size
determined by Northern blot. Where neither end was determined by Deep RACE, SIPHT-predicted coordinates are listed (underlined text).
doi:10.1371/journal.pone.0079411.t002
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processing of mRNA UTRs. Several features of the sRNAs
identified in this work are consistent with the sRNAs being
independently transcribed from their own promoters. First, the
Northern blots showed no evidence of larger bands that could
correspond to pre-processed mRNAs. Second, 13 sRNAs (Sm35,
Sm42, Sm67, Sm68, Sm74, Bo13, Bo32, Bo60, Bo71, Bo73, Bo81,
Bo118, Bo130) are orientated away from the surrounding genes.
Third, 5 sRNAs (Sm64, Sm82, Bo47, Bo105, Bo132) are located
.200 bp from the nearest gene start/stop. Nineteen sRNAs are
close to (,200 bp) upstream or downstream coding regions
(Sm11, Sm19, Sm32/33, Sm46, Sm47, Sm49, Sm76, Bo27, Bo29,
Bo35, Bo46, Bo48, Bo53, Bo78, Bo82, Bo86, Bo87, Bo96, Bo101)
and four (Sm38, Sm41, Sm90, Sm93) overlap coding regions in
Figure 4. Identification of sRNA 59 and 39 ends by Deep RACE. Blue lines show the number of 59 RACE reads mapped to respective genome,
while red lines show the number of 39 RACE reads. The coordinates with the highest number of mapped reads (the peak) indicate the likely 59 and 39
ends of sRNAs and are labeled in the figure. The orange arrow under the chart shows where the Northern probes base-paired and the blue arrows are
the adjacent annotated coding regions. Results for other sRNAs can be found in Figure S4.
doi:10.1371/journal.pone.0079411.g004
Figure 5. ChIP-seq peaks associated with predicted sRNA homologues in M. tuberculosis. ChIP-seq peaks that are unambiguously
associated with sRNA 59 ends. Raw ChIP-seq data from www.tbdb.org are shown for two transcription factors, (A) Rv2887, and (B) Rv3249c. Data are
shown for genomic regions surrounding (A) sRNA Bo132 (this work), and (B) sRNA B55 [12]. The green and blue graphs indicate the relative number
of sequence reads mapping to the plus and minus strands, respectively. The yellow graphs indicate the sum of plus and minus strand reads.
Annotated genes are shown as gray arrows. sRNAs are shown as red triangles.
doi:10.1371/journal.pone.0079411.g005
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generated by mRNA processing or premature termination,
although the Northern blot analysis argues against this. Regard-
less, sRNAs processed from mRNAs could still have important
regulatory functions [3,30,31]. Indeed, a recent study identified 39
UTRs as an abundant source of regulatory sRNAs in Salmonella
enterica [32]. Alternatively, sRNAs generated by processing of
mRNAs could indicate cis-acting regulatory elements such as
riboswitches.
Likely Regulators of sRNAs Identified by Analysis of ChIP-
seq Datasets
The regulation of sRNAs can provide important clues as to their
biological functions. However, very little is currently known about
regulation of mycobacterial sRNAs. The genome-wide binding
profiles of many M. tuberculosis transcription factors have recently
been determined using ChIP-seq and these data are publicly
available [25]. Although we identified sRNAs in M. bovis BCG, it is
highly likely that these sRNAs are conserved in M. tuberculosis given
the extremely high similarity of the M. bovis BCG and M.
tuberculosis genomes [33]. Hence, we searched existing ChIP-seq
datasets of M. tuberculosis for transcription factors that bind close to
sRNA 59 ends, including sRNAs identified in earlier studies [12].
We identified 10 ChIP-seq peaks (indicative of a transcription
factor binding site) located between 100 bp upstream and 20 bp
downstream of sRNA 59 ends (Table S5). Thus, we have identified
likely examples of sRNA regulation. In some cases, the ChIP-seq
peak is also close to the start of an annotated protein-coding gene.
Hence, the transcription factor may regulate the protein-coding
gene rather than the sRNA. Nevertheless, in four cases, the ChIP-
seq peak is unambiguously associated with an sRNA 59 end. The
two examples with highest ChIP-seq signal are shown in Figure 5.
For each of these examples, the transcription factor is otherwise
uncharacterized.
Conclusion
In summary, we have identified 17 novel sRNAs in M. smegmatis
and 23 novel sRNAs in M. bovis BCG, verified 59 and 39 ends, and
list these sRNAs according to a recently-proposed annotation
nomenclature. Our analysis of sRNA position relative to protein-
coding genes suggests various potential roles for these sRNAs in
gene regulation. Although the specific biological function of these,
and all other known mycobacterial sRNAs, is not understood, we
speculate that some of these sRNAs contribute to the biology of
pathogenic mycobacterial species. Future studies will focus on the
functional characterization of these novel sRNAs.
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